4.7 Article

Excess hydrogen sulfide and polysulfides production underlies a schizophrenia pathophysiology

Journal

EMBO MOLECULAR MEDICINE
Volume 11, Issue 12, Pages -

Publisher

WILEY
DOI: 10.15252/emmm.201910695

Keywords

energy metabolism; epigenetics; hydrogen sulfide and polysulfides; prepulse inhibition; proteomics

Funding

  1. Japan Agency for Medical Research and Development (AMED) [JP18dm0107083, JP19dm0107083, JP18dm0107085, JP19dm0107119, JP19dm0908001, 19dm0107086, 19dm0107107]
  2. MEXT [JP18H05435, JP18H05428, JP16H06277]
  3. JSPS KAKENHI [JP17H01574]

Ask authors/readers for more resources

Mice with the C3H background show greater behavioral propensity for schizophrenia, including lower prepulse inhibition (PPI), than C57BL/6 (B6) mice. To characterize as-yet-unknown pathophysiologies of schizophrenia, we undertook proteomics analysis of the brain in these strains, and detected elevated levels of Mpst, a hydrogen sulfide (H2S)/polysulfide-producing enzyme, and greater sulfide deposition in C3H than B6 mice. Mpst-deficient mice exhibited improved PPI with reduced storage sulfide levels, while Mpst-transgenic (Tg) mice showed deteriorated PPI, suggesting that sulfide stress may be linked to PPI impairment. Analysis of human samples demonstrated that the H2S/polysulfides production system is upregulated in schizophrenia. Mechanistically, the Mpst-Tg brain revealed dampened energy metabolism, while maternal immune activation model mice showed upregulation of genes for H2S/polysulfides production along with typical antioxidative genes, partly via epigenetic modifications. These results suggest that inflammatory/oxidative insults in early brain development result in upregulated H2S/polysulfides production as an antioxidative response, which in turn cause deficits in bioenergetic processes. Collectively, this study presents a novel aspect of the neurodevelopmental theory for schizophrenia, unraveling a role of excess H2S/polysulfides production.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Review Genetics & Heredity

Genetics of bipolar disorder: insights into its complex architecture and biology from common and rare variants

Tomonori Hara, Yuji Owada, Atsushi Takata

Summary: In this review, the recent advancements in the genetics of bipolar disorder (BD) are summarized, including the discovery of disease-associated loci, improved understanding of BD biology, correlations with other psychiatric disorders and behavioral traits, methods for predicting disease risk and drug response, and the identification of a single gene associated with bipolar disorder and schizophrenia spectrum. However, these findings have not yet had a clear impact on the improvement of clinical psychiatry of BD.

JOURNAL OF HUMAN GENETICS (2023)

Review Clinical Neurology

Maiden voyage: induced pluripotent stem cell-based drug screening for amyotrophic lateral sclerosis

Daisuke Ito, Satoru Morimoto, Shinichi Takahashi, Kensuke Okada, Jin Nakahara, Hideyuki Okano

Summary: Significant progress has been made in drug screening for amyotrophic lateral sclerosis using patient-derived induced pluripotent stem cells, leading to the identification of candidate drugs and the advancement of clinical trials. This stem cell-based approach shows safety and positive effects, reducing costs and time compared to animal testing.

BRAIN (2023)

Article Neurosciences

Ketamine and its metabolites: Potential as novel treatments for depression

Kai Zhang, Yitan Yao, Kenji Hashimoto

Summary: Ketamine is a rapid antidepressant that can alleviate depressive symptoms within hours. However, its specific mechanisms of action are not yet clear, and it has several side effects. Understanding the pharmacological properties and mechanisms of ketamine can help develop a new generation of rapid antidepressants.

NEUROPHARMACOLOGY (2023)

Article Behavioral Sciences

Rapid antidepressant-like effect of non-hallucinogenic psychedelic analog lisuride, but not hallucinogenic psychedelic DOI, in lipopolysaccharide-treated mice

Youge Qu, Lijia Chang, Li Ma, Xiayun Wan, Kenji Hashimoto

Summary: This study compared the effects of hallucinogenic psychedelic drug DOI, non-hallucinogenic psychedelic analog lisuride, and novel antidepressant (R)-ketamine on depression-like behavior and dendritic spine density in the brain. It was found that lisuride and (R)-ketamine improved these changes, while DOI did not. This suggests that the antidepressant-like effect of lisuride is not associated with 5-HT2AR-related psychedelic effects.

PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2023)

Article Clinical Neurology

A role of gut-microbiota-brain axis via subdiaphragmatic vagus nerve in depression-like phenotypes in Chrna7 knock-out mice

Yong Yang, Akifumi Eguchi, Xiayun Wan, Lijia Chang, Xingming Wang, Youge Qu, Chisato Mori, Kenji Hashimoto

Summary: This study suggests that Chrna7 knockout mice exhibit depression-like behaviors and reduced expression of synaptic proteins in the medial prefrontal cortex through the gut-microbiota-brain axis via the subdiaphragmatic vagus nerve. Subdiaphragmatic vagotomy can block these depression-like behaviors and alter the composition of gut microbiota and microbiota-derived metabolites.

PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2023)

Article Psychiatry

Repeated use of 3,4-methylenedioxymethamphetamine is associated with the resilience in mice after chronic social defeat stress: A role of gut-microbiota-brain axis

Youge Qu, Akifumi Eguchi, Xiayun Wan, Li Ma, Lijia Chang, Jiajing Shan, Yong Yang, Chisato Mori, Kenji Hashimoto

Summary: 3,4-Methylenedioxymethamphetamine (MDMA), the most widely used illicit compound worldwide, may contribute to stress resilience in mice subjected to chronic social defeat stress (CSDS) through the gut-microbiota-brain axis. The study found that MDMA treatment prevented the negative effects of CSDS, such as splenomegaly, anhedonia-like phenotype, and increased interleukin-6 (IL-6) levels in the mice. Gut microbiome analysis revealed differences between the saline + CSDS group and the MDMA + CSDS group, while metabolomics analysis showed altered plasma levels of N-epsilon-methyl-L-lysine in the saline + CSDS group compared to the control and MDMA + CSDS groups.

PSYCHIATRY RESEARCH (2023)

Article Clinical Neurology

Risk of esketamine anesthesia on the emergence delirium in preschool children after minor surgery: a prospective observational clinical study

Sai Chen, Jin-Jin Yang, Yue Zhang, Lei Lei, Di Qiu, Hui-Min Lv, Zhen-Tao Sun, Kenji Hashimoto, Jian-Jun Yang

Summary: This study investigated the effects of a single-dose of esketamine during anesthesia induction on emergence delirium (ED) in preschool children after minor surgery. The study found that the use of esketamine was associated with a higher incidence and score of ED, as well as a longer post-anesthesia care unit stay. However, there were no significant differences in other outcomes between the two groups. Therefore, the use of esketamine in preschool children for minor surgery should be noticed.

EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE (2023)

Review Clinical Neurology

Arketamine for cognitive impairment in psychiatric disorders

Kenji Hashimoto

Summary: Cognitive impairment is a common feature in various psychiatric disorders, and current therapeutic drugs do not effectively improve it. However, (R,S)-ketamine, particularly (R)-ketamine, has shown potential in improving cognitive impairment. The gut-microbiome-brain axis may also play a role in cognitive impairment in psychiatric disorders.

EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE (2023)

Article Immunology

Impact of broad-spectrum antibiotics on the gut-microbiota-spleen-brain axis

Xiayun Wan, Akifumi Eguchi, Akemi Sakamoto, Yuko Fujita, Yong Yang, Youge Qu, Masahiko Hatano, Chisato Mori, Kenji Hashimoto

Summary: Depletion of gut microbiota induced by antibiotic administration affects spleen and brain function, leading to decreased spleen weight and altered immune cell populations. Depletion of gut microbiota also leads to changes in metabolite levels, affecting spleen and brain function.

BRAIN, BEHAVIOR, & IMMUNITY - HEALTH (2023)

Article Psychiatry

A role of splenic heme biosynthesis pathway in the persistent prophylactic actions of arketamine in lipopolysaccharide-treated mice

Li Ma, Long Wang, Youge Qu, Xiayun Wan, Kenji Hashimoto

Summary: Relapse is common in remitted patients with major depressive disorder (MDD). Arketamine, an (R)-enantiomer of ketamine, has persistent prophylactic actions in an inflammatory model of depression. The heme biosynthesis II pathway in the spleen could be a new target for the prevention of relapse in MDD patients.

TRANSLATIONAL PSYCHIATRY (2023)

Review Medicine, General & Internal

A Review of Treatment Methods Focusing on Human Induced Pluripotent Stem Cell-Derived Neural Stem/Progenitor Cell Transplantation for Chronic Spinal Cord Injury

Takahiro Shibata, Syoichi Tashiro, Masaya Nakamura, Hideyuki Okano, Narihito Nagoshi

Summary: Cell transplantation therapy using human-induced pluripotent stem cell-derived neural stem/progenitor cells has shown efficacy in treating the subacute phase of spinal cord injury. However, there is a lack of focus on treatment in the chronic phase, which poses challenges in overcoming factors specific to chronic SCI. Combining different therapies and addressing issues in severe injury models and functional recovery are important for regenerative therapy in chronic SCI.

MEDICINA-LITHUANIA (2023)

Article Geriatrics & Gerontology

Epigenetic profile of Japanese supercentenarians: a cross- sectional study

Shohei Komaki, Masatoshi Nagata, Eri Arai, Ryo Otomo, Kanako Ono, Yukiko Abe, Hideki Ohmomo, So Umekage, Natsuko Shinozaki, Tsuyoshi Hachiya, Yoichi Sutoh, Yayoi Otsuka-Yamasaki, Yasumichi Arai, Nobuyoshi Hirose, Akio Yoneyama, Hideyuki Okano, Makoto Sasaki, Yae Kanai, Atsushi Shimizu

Summary: This study explored the epigenetic signatures of exceptional healthy longevity and found that it depends not only on maintaining young epigenetic states but also on advanced states of specific epigenetic regions.

LANCET HEALTHY LONGEVITY (2023)

Review Biochemistry & Molecular Biology

Induced pluripotent stem cells-based disease modeling, drug screening, clinical trials, and reverse translational research for amyotrophic lateral sclerosis

Hideyuki Okano, Satoru Morimoto, Chris Kato, Jin Nakahara, Shinichi Takahashi

Summary: In recent years, clinical trials using iPSC technology for disease modeling and drug discovery have shown promising results, particularly for the treatment of ALS. ROPi has been identified as a potential ALS treatment and has undergone clinical trials and reverse translational research, demonstrating its ability to delay disease progression and prolong survival in ALS patients.

JOURNAL OF NEUROCHEMISTRY (2023)

Article Neurosciences

Infusions of beta-hydroxybutyrate, an endogenous NLRP3 inflammasome inhibitor, produce antidepressant-like effects on learned helplessness rats through BDNF-TrkB signaling and AMPA receptor activation, and strengthen learning ability

Yukihiko Shirayama, Masaaki Iwata, Kanako Miyano, Yuki Hirose, Yasunori Oda, Yuko Fujita, Kenji Hashimoto

Summary: Beta-hydroxybutyrate (BHB) has shown antidepressant-like effects in a rat model of depression. It activates the BDNF-TrkB signaling pathway and AMPA receptors, and is associated with the prefrontal cortex, hippocampus, and basolateral region of amygdala.

BRAIN RESEARCH (2023)

Correction Biochemistry & Molecular Biology

Brain-specific heterozygous loss-of-function of ATP2A2, endoplasmic reticulum Ca2+ pump responsible for Darier's disease, causes behavioral abnormalities and a hyper-dopaminergic state (vol 30, pg 1762, 2021)

Kazuo Nakajima, Mizuho Ishiwata, Adam Z. Weitemier, Hirotaka Shoji, Hiromu Monai, Hiroyuki Miyamoto, Kazuhiro Yamakawa, Tsuyoshi Miyakawa, Thomas J. McHugh, Tadafumi Kato

HUMAN MOLECULAR GENETICS (2023)

No Data Available